Диссертация (1139687), страница 36
Текст из файла (страница 36)
– Vol. 45. – N 12. – P. 1798–1804.289. Structure and chemistry of cytochrome P450 / I. G. Denisov [et al.] //Chem Rev. – 2005. – Vol. 105. – N 6. – P. 2253–2277.290. Structure and function of cytochromes p450: A comparative analysis ofthree crystal structures / C. A. Hasemann [et al.] // Structure. – 1995.
– Vol. 3 – P. 41–62.291. Study of urinary 6beta-hydroxycortisol/cortisol ratio in spot urine sampleas a biomarker of 3A4 enzyme activity in healthy and epileptic subjects of Egyptianpopulation / E. S. Eldesoky [et al.] // Pharmacol Res.
– 2005. – Vol. 51. – N 6. – P. 575–580.223292. Subtle structural changes in the Asp251Gly/Gln307His P450 BM3 mutantresponsible for new activity toward diclofenac, tolbutamide and ibuprofen / G. DiNardo [et al.] // Arch Biochem Biophys. – 2016. – Vol. 602 – P. 106–115.293. Szklarz, G. D. Molecular basis of P450 inhibition and activation:implications for drug development and drug therapy / G. D. Szklarz, J.
R. Halpert //Drug Metab Dispos. – 1998. – Vol. 26. – N 12. – P. 1179–1184.294. Taurine protects acetaminophen-induced oxidative damage in mice kidneythrough APAP urinary excretion and CYP2E1 inactivation / Das J. [et al.] //Toxicology. – 2010. – Vol. 269 – P. 24–34.295. The antioxidant action of taurine, hypotaurine and their metabolicprecursors / O.
I. Aruoma [et al.] // Biochem J. – 1988. – Vol. 256. – P. 251–255.296. The antioxidant alpha-lipoic acid improves endothelial dysfunction inducedby acute hyperglycaemia during OGTT in impaired glucose tolerance / G. D. Xiang [etal.] // Clin Endocrinol (Oxf). – 2008. – Vol. 68. – N 5. – P. 716–723.297. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memoryimpairment and brain oxidative stress in aged SAMP8 mice / S. A. Farr [et al.] // JNeurochem. – 2003.
– Vol. 84. – N 5. – P. 1173–1183.298. The dose-dependent influence of vitamins with antioxidant properties onelectrochemically-driven cytochromes P450 catalysis / V. V. Shumyantseva [et al.] //Oxidants and Antioxidants in Medical Science. – 2013. – Vol. 2 – N 2. P. 113–117.299.
The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4mouse as a model of human Alzheimer's disease / J. C. Shenk [et al.] // J Neurol Sci. –2009. – Vol. 283. – N 1–2. – P. 199–206.300. The influence of B-group vitamins on monooxygenase activity ofcytochrome P450 3A4: Pharmacokinetics and electro analysis of the catalytic properties/ V. V. Shumyantseva [et al.] // Biochemistry (Moscow) Supplement Series B:Biomedical Chemistry. – 2012. – Vol. 6. – N 1. – P.
87–93.301. The potent free radical scavenger alpha-lipoic acid improves memory inaged mice: putative relationship to NMDA receptor deficits / S. Stoll [et al.] //Pharmacol Biochem Behav. – 1993. – Vol. 46. – N 4. – P. 799–805.224302. The structure of human microsomal cytochrome P450 3A4 determined byX-ray crystallography to 2.05-Å resolution / J.
K. Yano [et al.] // J Biol Chem. – 2004. –Vol. 279. – N. 37. – P. 38091–38094.303. The thiamine status of adult humans depends on carbohydrate intake /I. Elmadfa [et al.] // Int J Vitam Nutr Res 2001. – Vol. 71. – P. 217–221.304. Thioctic acid – effects on insulin sensitivity and glucose – metabolism /S. Jacob [et al.] // Biofactors. – 1999. – Vol. 10. – N 2–3 – P. 169–174.305. Thirty years of microbial P450 monooxygenase research: peroxo-hemeintermediates — The central bus station in heme oxygenase catalysis / S.
G. Sligar [etal.] // Biochem. Biophys. Res. Commun. – 2005. – Vol.338. – N 1. – P. 346–354.306. Topical taurine bromamine, a new candidate in the treatment of moderateinflammatory acne vulgaris: a pilot study / J. Marcinkiewicz [et al.] // Eur J Dermatol. –2008. – Vol. 18. – N 4. – P. 433–439.307. Treatment of symptomatic diabetic polyneuropathy with the antioxidantalpha-lipoic acid: a meta-analysis / D. Ziegler [et al.] // Diabet Med.
– 2004. – Vol. 21.– N 2. – P. 114–121.308. Uptake, recycling, and antioxidant actions of alpha-lipoic acid inendothelial cells / W. Jones. [et al.] // Free Radic Biol Med. – 2002. – Vol. 33. – N 1 –P. 83–93.309. Ubiquinol-10 and total peroxil radical trapping capacity of LDLlipoproteins during aging: the effects of Q-10 supplementation / R. Aejmelaeus [et al.
]// Mol. Aspects Med. – 1997. – Vol. 18. – Suppl. 1. – P 113–120.310. Urlacher, V. B. Microbial P450 enzymes in biotechnology / V. B. Urlacher,S. Lutz-Wahl, R. D. Schmid // Appl Microbiol Biotechnol. – 2004. – Vol. 64. – N 3. –P. 317–325.311. VandenBrink, B. M. The role of metabolites in predicting drug-druginteractions: focus on irreversible cytochrome P450 inhibition / B. M. VandenBrink,N.
Isoherranen // Curr Opin Drug Discov Devel – 2010. – Vol. 13. – N 1. – P. 66–77.312. Vitamin C / J. Higdon [et al.] // Linus Pauling Institute MicronutrientInformationCenter[electronicresource].–availableat:http://225lpi.oregonstate.edu/infocenter/vitamins/vitaminC/index.html#disease_prevention(access date: 10/7/2015).313. Vitamin E / J. Higdon [et al.] // Linus Pauling Institute MicronutrientInformationCenter[electronicresource].–availableat:http://lpi.oregonstate.edu/infocenter/vitamins/vitaminE/ (access date: 01/7/2015).314. Vitamin E activates gene expression via the pregnane X receptor /N. Landes [et al.] // Biochem Pharmacol.
– 2003. – Vol. 65 – P. 269–273.315. Vivid® CYP450 Screening Kits [electronic resource]. – available at:http://tools.thermofisher.com/content/sfs/manuals/Vivid_CYP450_Screening_Kits_man.pdf (access date: 14/7/2015).316. von Kries, J. P. Identification of small-molecule scaffolds for P450inhibitors / J. P. von Kries, T. Warrier, L. M. Podust // Curr Protoc Microbiol. – 2010. –Ch. 17.
– Unit 17.4.317. Walther, T. C. Mass spectrometry-based proteomics in cell biology /T. C. Walther, M. Mann // J. Cell Biol. – 2010. – Vol. 190. – N 4 – P. 491–500.318. Wilkinson, G. R. Cytochrome P4503A (CYP3A) metabolism: prediction ofin vivo activity in humans / G. R. Wilkinson // J Pharmacokinet Biopharm.
– 1996. –Vol. 24. – N 5. – P. 475–490.319. Xue-Jun Zhao, T. I. Metabolic interactions of selected antimalarial andnon-antimalarial drugs with the major pathway (3-hydroxylation) of quinine in humanliver microsomes / T. I. Xue-Jun Zhao, T. Ishizaki // Br J Clin Pharmacol. – 1997. –Vol. 44. – N. 5. – P. 505–511.320. Yamazaki, H. Roles of human cytochrome P450 enzymes involved in drugmetabolism and toxicological studies / H.
Yamazaki // Yakugaku Zasshi. – 2000. –Vol. 120. – N. 12. – P. 1347–1357.321. Yamazaki, H. Cytochrome P450 reconstitution systems / H. Yamazaki,T. Shimada // Methods Mol Biol. – 2006. – Vol. 320 – P. 61–71.322. Yang, C. S. Dietary effects on cytochromes P450, xenobiotic metabolism,and toxicity / C. S. Yang, J. F. Brady, J. Y. Hong // FASEB J. – 1992.
– Vol. 6. – N 2. –P. 737–744.226323. Yarman, A. Sensors based on cytochrome p450 and cyp mimickingsystems / A. Yarman, U. Wollenberger, F. W Scheller // Electrochimica Acta. – 2013. –Vol. 110. – P. 63–72.324. Yoshimoto, F. K. The diverse chemistry of cytochrome P450 17A1(P450c17, CYP17A1) / F.
K. Yoshimoto, R. J. Auchus // Journal of SteroidBiochemistry & Molecular Biology. – 2015. – Vol. 151 – P. 52–65.325. Zafirlukast metabolism by cytochrome P450 3A4 produces an electrophilicalpha,beta-unsaturated iminium species that results in the selective mechanism-basedinactivation of the enzyme / K. Kassahun [et al.] // Chem Res Toxicol. – 2005. –Vol. 18 – P. 1427–1437.326. Zangar, R.
C. Mechanisms that regulate production of reactive oxygenspecies by cytochrome P450 / R. C. Zangar, D. R. Davydov, S. Verma // Toxicol ApplPharmacol. – 2004. – Vol. 199. – N 3. – P. 316–331.327. Zhang, X. Prediction of the Effect of Erythromycin, Diltiazem, and theirMetabolites, Alone and in Combination, on CYP3A4 Inhibition.
/ X. Zhang.D. R. Jones, S. D. Hall // Drug Metab Dispos. – 2009. – Vol. 37. – N 1. – P. 150–160.328. Zhou, S. F. Drugs behave as substrates, inhibitors and inducers of humancytochrome P450 3A4 / S. F. Zhou // Curr Drug Metab. – 2008. – Vol. 9. – N 4. –P.
310–322..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
